Cancer care continuum: Prevention > Detection > Diagnosis > Treatment > Survivorship
Treatment is the fourth phase of the cancer care continuum. Our faculty members are often working with clinicians and patients to understand and help improve health outcomes. Through provider and patient communication, research in this area is targeted at improving patient outcome and satisfaction.
- Health care delivery and outcomes research
- Informed and shared decision making
Faculty involved: Graham Colditz, Aimee James, Erin Linnenbringer, Mary Politi, Siobhan Sutcliffe
The partnership between The Southern Illinois University School of Medicine and Siteman Cancer Center investigates rural cancer disparities and ways to help educate, train, and implement effective strategies to reduce the disparities seen in rural communities.
Faculty Involved: Erika Waters, Jean Hunleth
Drs. Waters, Hunleth, and colleagues will used a mixed methods research design to gain in-depth understanding of the psychological and social factors that shape the decision making process that caregivers use to care for their asthmatic children. This project will provide evidence-based behavioral strategies to improve the lives of 6.2 million children who are affected by asthma.
Faculty involved: Mary Politi, Bettina Drake, Esther Lu, Aimee James, Jean Hunleth, Erika Waters, PhD, MPH, Vetta Sanders Thompson, Graham Colditz
This line of research strives to engage all members of the community throughout the research process to help navigate the healthcare process.
Faculty involved: Yin Cao
Dr. Yin Cao received a Young Investigator Award from the National Comprehensive Cancer Network. This two-year award will support Dr. Cao in her work addressing colorectal cancer survival disparities among patients diagnosed under age 50 through integrating patients, treatment, and tumor molecular characteristics.
Faculty involved: Siobhan Sutcliffe, Aimee James
The MAPP study is a cohort study of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) from six sites across the United States. It was designed to better understand the natural history of these conditions and their underlying causes, taking a “whole-body” rather than a bladder- or prostate-specific approach.
Faculty involved: Mary Politi
This project will develop a preference-sensitive decision support tool for patients considering breast reconstruction after mastectomy. The tool will provide patient education, elicit patients’ preferences, and include personalized risk prediction to aid in the decision making process.
Faculty involved: Aimee James, Siobhan Sutcliffe
The PLUS Research Network is a multi-site network designed to develop the evidence base for future clinical trials to prevent the development and progression of lower urinary tract symptoms in women and girls. Current projects include a qualitative focus group study, the development of new instruments to measure bladder health, systematic reviews of the literature, and analyses of existing study data to better understand bladder health and factors that contribute to the development and progression of lower urinary tract symptoms.
Faculty involved: Aimee James, Graham Colditz, Vetta Sanders Thompson, Bettina Drake, Esther Lu, Jean Hunleth
Community-based participatory research (CBPR) helps give community members voice in academic research. These projects evaluated current and past CBPR projects to discovery future best practices.
Faculty involved: Graham Colditz, Aimee James, Bettina Drake, Vetta Sanders Thompson
The mission of Siteman Cancer Center’s Program for the Elimination of Cancer Disparities (PECaD) is to create a national model for eliminating local and regional disparities in cancer education, prevention and treatment. Through a community advisory committee and community partnerships, PECaD works with community representatives to find solutions that reduce disparities.
Faculty involved: Bettina Drake
The Prostate Cancer Biorepository Network (PCBN) is a Department of Defense (DOD)/ Congressionally Directed Medical Research Program (CDMRP) bioresource that provides tissue and other biospecimens to all prostate cancer investigators.
Faculty involved: Bettina Drake, Graham Colditz
The long-term goal of this collaboration between Dr. Drake and The St. Louis Mens Group Against Cancer is to be able to identify patients with increased risk for dying of prostate cancer while they are still treatable.
Faculty involved: Graham Colditz, Siobhan Sutcliffe, Bettina Drake
The PIE study is a cohort study of prostate cancer survivors who underwent prostate surgery at Washington University School of Medicine and Brigham & Women’s Hospital. These men were followed for one year after their surgery to better understand the natural history of treatment side effects, such as urinary incontinence and sexual dysfunction, and possible factors that influence the natural history of these side effects, such as physical activity and obesity.
Faculty involved: Adetunji Toriola, Graham Colditz, Rosy Luo
A very dense breast on mammogram is one of the strongest risk factors for breast cancer, and many women in the United States have extremely dense breasts. There is, however, very limited knowledge on how to modify breast density to reduce breast cancer risk
Faculty involved: Siobhan Sutcliffe
This project, the Department of Defense Serum Repository Study of the Influence of Infections on Biomarkers of Prostate Pathology, is nested within the large population of men on active U.S. military duty with stored blood samples in the Department of Defense Serum Repository. The project examines the short- and longer-term influence of genitourinary and non-genitourinary infections on biomarkers of prostate pathology to inform the possible influence of infections on later prostate cancer risk.
Faculty involved: Aimee James
Nonadherence can have significant negative health effects for the individual and contribute to increases in hospitalization, healthcare costs, and mortality. Adherence is a complex issue, but cost and affordability of medication is a common and critical barrier.The short-term objective is to identify how patients and healthcare providers approach affordability and adherence and use those data to refine and pilot test an intervention promoting patient-provider discussion about cost, affordability, and adherence. The long- term objective is to deliver interventions to reduce cost-related nonadherence.
Faculty involved: Graham Colditz, Erika Waters, PhD, MPH, Adetunji Toriola, Bettina Drake, Siobhan Sutcliffe, Yikyung Park
Personalized health assessment tool that allows people to see their risk for common chronic conditions, such as diabetes, heart disease, stroke, and cancer risk.